An article by Captario Head of Science, Stig Johan Wiklund, published in the Journal of Biopharmaceutical Statistics. Abstract The...

This paper presents the study of multi-objective optimization of a pharmaceutical portfolio when both cost and return values are...

An article by Captario Head of Science, Stig Johan Wiklund, on selection bias in phase 3 projects! Abstract When making decisions...

Captario Analyst, Maboubeh Farid et al, features in the Journal of Mathematics in Industry with her article "Pharmaceutical Portfolio...

The development of a new drug is an extremely high-risk enterprise. The attrition rates of development projects and the average costs for...